{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T02:48:38Z","timestamp":1791946118755,"version":"4.3.4"},"reference-count":56,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T00:00:00Z","timestamp":1769558400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000268","name":"Biotechnology and Biological Sciences Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000268","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013342","name":"National Institute for Health Research Imperial Biomedical Research Centre","doi-asserted-by":"publisher","award":["P45058"],"award-info":[{"award-number":["P45058"]}],"id":[{"id":"10.13039\/501100013342","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018336","name":"National Institute for Health Research Health Protection Research Unit","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005612","name":"Shionogi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005612","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","mucosalimmunology.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mucosal Immunology"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.mucimm.2026.01.012","type":"journal-article","created":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T00:29:03Z","timestamp":1770683343000},"page":"1907-1921","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Mucosal IL-36 is a defining feature of severe paediatric bronchiolitis"],"prefix":"10.1016","volume":"19","author":[{"given":"Megan V.C.","family":"Barnes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie W.H.","family":"Stretch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawid","family":"Swieboda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Efstathiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona J.","family":"Culley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trevor T.","family":"Hansel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sam","family":"Strickson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Romero-Ros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. Suzanne","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Nadel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J.M.","family":"Openshaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3052-2793","authenticated-orcid":false,"given":"Ryan S.","family":"Thwaites","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mucimm.2026.01.012_b0005","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1136\/thoraxjnl-2018-212212","article-title":"Respiratory syncytial virus (RSV): a scourge from infancy to old age","volume":"74","author":"Coultas","year":"2019","journal-title":"Thorax."},{"key":"10.1016\/j.mucimm.2026.01.012_b0010","article-title":"Risk factors for respiratory syncytial virus associated with acute lower respiratory infection in children under five years: Systematic review and meta-analysis","volume":"5","author":"Shi","year":"2015","journal-title":"J Glob Health."},{"key":"10.1016\/j.mucimm.2026.01.012_b0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12879-015-1218-z","article-title":"Modelling estimates of the burden of respiratory Syncytial virus infection in adults and the elderly in the United Kingdom","volume":"15","author":"Fleming","year":"2015","journal-title":"BMC Infect Dis."},{"key":"10.1016\/j.mucimm.2026.01.012_b0020","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1542\/peds.2014-1665","article-title":"Updated guidance for palivizumab prophylaxis among infants and young children at increased risk of hospitalization for respiratory syncytial virus infection","volume":"134","author":"Brady","year":"2014","journal-title":"Pediatrics."},{"key":"10.1016\/j.mucimm.2026.01.012_b0025","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1056\/NEJMc2214773","article-title":"Nirsevimab for prevention of RSV in term and late-preterm infants","volume":"388","author":"Muller","year":"2023","journal-title":"N Engl J Med."},{"key":"10.1016\/j.mucimm.2026.01.012_b0030","unstructured":"A Trial to Evaluate the Efficacy and Safety of RSVpreF in Infants Born to Women Vaccinated During Pregnancy. - Full Text View - ClinicalTrials.gov. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04424316?type=Intr&cond=rsv&phase=2&draw=3."},{"key":"10.1016\/j.mucimm.2026.01.012_b0035","unstructured":"A Phase III Double-blind Study to Assess Safety and Efficacy of an RSV Maternal Unadjuvanted Vaccine, in Pregnant Women and Infants Born to Vaccinated Mothers - Full Text View - ClinicalTrials.gov. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04605159?type=Intr&cond=rsv&phase=2&draw=2."},{"key":"10.1016\/j.mucimm.2026.01.012_b0040","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1056\/NEJMoa2216480","article-title":"Bivalent prefusion F vaccine in pregnancy to prevent RSV illness in infants","volume":"388","author":"Kampmann","year":"2023","journal-title":"N Engl J Med."},{"key":"10.1016\/j.mucimm.2026.01.012_b0045","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1164\/rccm.201712-2567OC","article-title":"Reduced nasal viral load and IFN responses in infants with respiratory syncytial virus bronchiolitis and respiratory failure","volume":"198","author":"Thwaites","year":"2018","journal-title":"Am J Respir Crit Care Med."},{"key":"10.1016\/j.mucimm.2026.01.012_b0050","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1164\/rccm.201812-2366OC","article-title":"Elevated levels of type 2 respiratory innate lymphoid cells in human infants with severe respiratory syncytial virus bronchiolitis","volume":"200","author":"Vu","year":"2019","journal-title":"Am J Respir Crit Care Med."},{"issue":"6","key":"10.1016\/j.mucimm.2026.01.012_b0055","first-page":"1","article-title":"Pattern recognition receptors in health and diseases","volume":"61","author":"Li","year":"2021","journal-title":"Signal Transduct Target Ther."},{"key":"10.1016\/j.mucimm.2026.01.012_b0060","doi-asserted-by":"crossref","first-page":"725","DOI":"10.3389\/fmicb.2022.865592","article-title":"Innate immune evasion by human respiratory syncytial virus","volume":"13","author":"Ouyang","year":"2022","journal-title":"Front Microbiol."},{"key":"10.1016\/j.mucimm.2026.01.012_b0065","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00365-2021","article-title":"Inflammatory epithelial cytokines after in vitro respiratory syncytial viral infection are associated with reduced lung function","volume":"7","author":"Duan","year":"2021","journal-title":"ERJ Open Res."},{"key":"10.1016\/j.mucimm.2026.01.012_b0070","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens8030106","article-title":"Airway epithelial derived cytokines and chemokines and their role in the immune response to respiratory syncytial virus infection","volume":"8","author":"Glaser","year":"2019","journal-title":"Pathogens."},{"key":"10.1016\/j.mucimm.2026.01.012_b0075","doi-asserted-by":"crossref","DOI":"10.3390\/v12080808","article-title":"The contribution of neutrophils to the pathogenesis of RSV bronchiolitis","volume":"12","author":"Sebina","year":"2020","journal-title":"Viruses."},{"key":"10.1016\/j.mucimm.2026.01.012_b0080","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.jaci.2015.06.034","article-title":"Neutrophils in respiratory syncytial virus infection: atarget for asthma prevention","volume":"136","author":"Geerdink","year":"2015","journal-title":"J Allergy Clin Immunol."},{"key":"10.1016\/j.mucimm.2026.01.012_b0085","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/bph.15318","article-title":"Neutrophils in respiratory syncytial virus infection: from harmful effects to therapeutic opportunities","volume":"178","author":"Tahamtan","year":"2021","journal-title":"Br J Pharmacol."},{"key":"10.1016\/j.mucimm.2026.01.012_b0090","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1093\/jleuko\/qiad011","article-title":"Trans-epithelial migration is essential for neutrophil activation during RSV infection","volume":"113","author":"Robinson","year":"2023","journal-title":"J Leukoc Biol."},{"key":"10.1016\/j.mucimm.2026.01.012_b0095","doi-asserted-by":"crossref","DOI":"10.1016\/B0-12-370879-6\/00048-X","article-title":"Bronchiolitis","volume":"268","author":"Smyth","year":"2006","journal-title":"Encycl Respir Med."},{"key":"10.1016\/j.mucimm.2026.01.012_b0100","doi-asserted-by":"crossref","DOI":"10.3390\/cells11071153","article-title":"Mucosal immune responses to respiratory syncytial virus","volume":"11","author":"Barnes","year":"2022","journal-title":"Cells."},{"key":"10.1016\/j.mucimm.2026.01.012_b0105","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1093\/infdis\/jiaa576","article-title":"Airway gene expression correlates of respiratory syncytial virus disease severity and microbiome composition in infants","volume":"223","author":"Chu","year":"2021","journal-title":"J Infect Dis."},{"key":"10.1016\/j.mucimm.2026.01.012_b0110","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1128\/JVI.02140-15","article-title":"Respiratory syncytial virus attachment glycoprotein contribution to infection depends on the specific fusion protein","volume":"90","author":"Meng","year":"2016","journal-title":"J Virol."},{"key":"10.1016\/j.mucimm.2026.01.012_b0115","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0266412","article-title":"An endogenously activated antiviral state restricts SARS-CoV-2 infection in differentiated primary airway epithelial cells","volume":"17","author":"Broadbent","year":"2022","journal-title":"PLoS One."},{"key":"10.1016\/j.mucimm.2026.01.012_b0120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0228229","article-title":"Comparative primary paediatric nasal epithelial cell culture differentiation and RSV-induced cytopathogenesis following culture in two commercial media","volume":"15","author":"Broadbent","year":"2020","journal-title":"PLoS One."},{"key":"10.1016\/j.mucimm.2026.01.012_b0125","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1177\/2211068214561025","article-title":"TEER measurement techniques for in vitro barrier model systems","volume":"20","author":"Srinivasan","year":"2015","journal-title":"J Lab Autom."},{"key":"10.1016\/j.mucimm.2026.01.012_b0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-018-25167-4","article-title":"An in vitro transepithelial migration assay to evaluate the role of neutrophils in respiratory Syncytial Virus (RSV) induced epithelial damage","volume":"8","author":"Deng","year":"2018","journal-title":"Sci Rep."},{"key":"10.1016\/j.mucimm.2026.01.012_b0135","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1089\/jir.2017.0127","article-title":"Development of a validated interferon score using nanostring technology","volume":"38","author":"Kim","year":"2018","journal-title":"J Interferon Cytokine Res."},{"issue":"8","key":"10.1016\/j.mucimm.2026.01.012_b0140","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/nrd2783","article-title":"Unleashing the therapeutic potential of NOD-like receptors","volume":"86","author":"Geddes","year":"2009","journal-title":"Nat Rev Drug Discov."},{"key":"10.1016\/j.mucimm.2026.01.012_b0145","first-page":"1207","article-title":"Viral load dynamics and clinical disease severity in infants with respiratory syncytial virus infection","volume":"2019","author":"Garcia-Mauri\u00f1o","year":"2018","journal-title":"J Infect Dis."},{"key":"10.1016\/j.mucimm.2026.01.012_b0150","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1507","article-title":"Single\u2010cell immune profiling reveals markers of emergency myelopoiesis that distinguish severe from mild respiratory syncytial virus disease in infants","volume":"13","author":"Zivanovic","year":"2023","journal-title":"Clin Transl Med."},{"key":"10.1016\/j.mucimm.2026.01.012_b0155","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1097\/PCC.0000000000000558","article-title":"The pediatric risk of mortality score: update 2015","volume":"17","author":"Pollack","year":"2016","journal-title":"Pediatr Crit Care Med."},{"key":"10.1016\/j.mucimm.2026.01.012_b0160","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1165\/rcmb.2010-0075OC","article-title":"Regulation and function of the IL-1 family cytokine IL-1F9 in human bronchial epithelial cells","volume":"45","author":"Chustz","year":"2011","journal-title":"Am J Respir Cell Mol Biol."},{"key":"10.1016\/j.mucimm.2026.01.012_b0165","doi-asserted-by":"crossref","DOI":"10.3390\/cells10071609","article-title":"RelB and neuroinflammation","volume":"10","author":"Mockenhaupt","year":"2021","journal-title":"Cells."},{"key":"10.1016\/j.mucimm.2026.01.012_b0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s42003-021-01703-3","article-title":"IL36 is a critical upstream amplifier of neutrophilic lung inflammation in mice","volume":"4","author":"Koss","year":"2021","journal-title":"Commun Biol."},{"key":"10.1016\/j.mucimm.2026.01.012_b0175","doi-asserted-by":"crossref","DOI":"10.1042\/BST20230548","article-title":"Molecular aspects of Interleukin-36 cytokine activation and regulation","author":"Keller","year":"2024","journal-title":"Biochem Soc Trans."},{"key":"10.1016\/j.mucimm.2026.01.012_b0180","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001549","article-title":"Whole blood gene expression profiles to assess pathogenesis and disease severity in infants with respiratory syncytial virus infection","volume":"10","author":"Mejias","year":"2013","journal-title":"PLoS Med."},{"key":"10.1016\/j.mucimm.2026.01.012_b0185","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/B978-0-12-397863-9.00003-1","article-title":"Immunoproteasomes: structure, function, and antigen presentation","volume":"109","author":"Ferrington","year":"2012","journal-title":"Prog Mol Biol Transl Sci."},{"key":"10.1016\/j.mucimm.2026.01.012_b0190","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/s41577-019-0165-0","article-title":"The NLRP3 inflammasome: molecular activation and regulation to therapeutics","volume":"19","author":"Swanson","year":"2019","journal-title":"Nat Rev Immunol."},{"key":"10.1016\/j.mucimm.2026.01.012_b0195","doi-asserted-by":"crossref","first-page":"L125","DOI":"10.1152\/ajplung.00074.2019","article-title":"Heme oxygenase-1 dampens the macrophage sterile inflammasome response and regulates its components in the hypoxic lung","volume":"318","author":"Vitali","year":"2020","journal-title":"Am J Physiol Lung Cell Mol Physiol."},{"key":"10.1016\/j.mucimm.2026.01.012_b0200","article-title":"The role of NLRP3 inflammasome activation pathway of hepatic macrophages in liver ischemia\u2013reperfusion injury","volume":"13","author":"Wu","year":"2022","journal-title":"Front Immunol."},{"key":"10.1016\/j.mucimm.2026.01.012_b0205","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.00211","article-title":"NLRP3 inflammasome\u2014a key player in antiviral responses","volume":"11","author":"Zhao","year":"2020","journal-title":"Front Immunol."},{"key":"10.1016\/j.mucimm.2026.01.012_b0210","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2108728118","article-title":"A novel class of TMPRSS2 inhibitors potently block SARS-CoV-2 and MERS-CoV viral entry and protect human epithelial lung cells","volume":"118","author":"Mahoney","year":"2021","journal-title":"PNAS."},{"key":"10.1016\/j.mucimm.2026.01.012_b0215","unstructured":"Single cell type - IL36A - The Human Protein Atlas. https:\/\/www.proteinatlas.org\/ENSG00000136694-IL36A\/single+cell."},{"key":"10.1016\/j.mucimm.2026.01.012_b0220","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0045784","article-title":"IL-36a exerts pro-inflammatory effects in the lungs of mice","volume":"7","author":"Ramadas","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.mucimm.2026.01.012_b0225","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13223-023-00868-2","article-title":"Different expression levels of interleukin-36 in asthma phenotypes","volume":"20","author":"Li","year":"2024","journal-title":"Allergy, Asthma Clin Immunol."},{"key":"10.1016\/j.mucimm.2026.01.012_b0230","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2021.754702","article-title":"Interleukin-36 cytokines in infectious and non-infectious lung diseases","volume":"12","author":"Pe\u00f1aloza","year":"2021","journal-title":"Front Immunol."},{"key":"10.1016\/j.mucimm.2026.01.012_b0235","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/j.jaci.2023.01.015","article-title":"IL-1 receptor antagonist attenuates proinflammatory responses to rhinovirus in airway epithelium","volume":"151","author":"Schworer","year":"2023","journal-title":"J Allergy Clin Immunol."},{"key":"10.1016\/j.mucimm.2026.01.012_b0240","article-title":"Spesolimab: a review of the first IL-36 blocker approved for generalized pustular psoriasis","author":"Pathak","year":"2024","journal-title":"Ann Pharmacother."},{"key":"10.1016\/j.mucimm.2026.01.012_b0245","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1038\/s41467-025-56601-7","article-title":"Discovery of selective low molecular weight interleukin-36 receptor antagonists by encoded library technologies","volume":"16","author":"Velcicky","year":"2025","journal-title":"Nat Commun."},{"key":"10.1016\/j.mucimm.2026.01.012_b0250","doi-asserted-by":"crossref","DOI":"10.1126\/science.aba9301","article-title":"Neutrophilic inflammation in the respiratory mucosa predisposes to RSV infection","volume":"370","author":"Habibi","year":"2020","journal-title":"Science (80-.)"},{"key":"10.1016\/j.mucimm.2026.01.012_b0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.108515","article-title":"The proinflammatory cytokine IL-36g is a global discriminator of harmless microbes and invasive pathogens within epithelial tissues","volume":"33","author":"Macleod","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.mucimm.2026.01.012_b0260","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1136\/adc.88.10.922","article-title":"Bronchoalveolar lavage cellularity in infants with severe respiratory syncytial virus bronchiolitis","volume":"88","author":"McNamara","year":"2003","journal-title":"Arch Dis Child."},{"key":"10.1016\/j.mucimm.2026.01.012_b0265","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02161-19","article-title":"Neutrophil-airway epithelial interactions result in increased epithelial damage and viral clearance during respiratory syncytial virus infection","volume":"94","author":"Deng","year":"2020","journal-title":"J Virol."},{"key":"10.1016\/j.mucimm.2026.01.012_b0270","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1038\/s41385-022-00545-4","article-title":"Distinct airway epithelial immune responses after infection with SARS-CoV-2 compared to H1N1","volume":"15","author":"St\u00f6lting","year":"2022","journal-title":"Mucosal Immunol."},{"issue":"9","key":"10.1016\/j.mucimm.2026.01.012_b0275","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1038\/s41564-024-01658-1","article-title":"Age-specific nasal epithelial responses to SARS-CoV-2 infection","volume":"95","author":"Woodall","year":"2024","journal-title":"Nat Microbiol."},{"key":"10.1016\/j.mucimm.2026.01.012_b0280","doi-asserted-by":"crossref","DOI":"10.1136\/thorax-2023-220081","article-title":"Neutrophil responses to RSV infection show differences between infant and adult neutrophils","author":"Robinson","year":"2024","journal-title":"Thorax."}],"container-title":["Mucosal Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933021926000127?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933021926000127?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T07:22:50Z","timestamp":1782112970000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1933021926000127"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":56,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S1933021926000127"],"URL":"https:\/\/doi.org\/10.1016\/j.mucimm.2026.01.012","relation":{},"ISSN":["1933-0219"],"issn-type":[{"value":"1933-0219","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mucosal IL-36 is a defining feature of severe paediatric bronchiolitis","name":"articletitle","label":"Article Title"},{"value":"Mucosal Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mucimm.2026.01.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of Society for Mucosal Immunology.","name":"copyright","label":"Copyright"}]}}